Early research (Phase 1)Study completedNCT01459250
What this trial is testing
Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects
Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 32